Business Performance Review

P&L Highlights | Q2 & H1 FY24 Particulars (In Millions) Revenue from Operations Gross Profit Q2 FY24 Q1 FY24 QoQ Q2 FY23 YOY H1 FY24 H1 FY23 YOY 5,954 5,785 2.9% 5,093 16.9% 11,738 9,992 17.5% 3,223 3,304 -2.5% 2,693 19.7% 6,527 5,303 23.1% Gross Profit (%) 54.1% 57.1% 52.9% 55.6% 53.1% Other Income 54 18 198.2% 100 -46.3% 72 195 -63.0% Employee Benefits Expense 667 481 38.6% 474 40.7% 1,148 878 30.8% Other Expenses 885 891 -0.7% 783 13.0% 1,776 1,521 16.8% EBITDA 1,725 1,950 -11.5% 1,536 12.2% 3,675 3,099 18.6% EBITDA Margin (%) 29.0% 33.7% 30.2% 31.3% 31.0% Depreciation and Amortisation Expense 131 126 4.1% 99 32.9% 257 198 30.0% Finance Costs 4 4 0.6% 1 195.3% 8 3 164.9% PBT 1,589 1,820 -12.7% 1,436 10.7% 3,409 2,898 17.6% PBT Margin (%) 26.7% 31.5% 28.2% 29.0% 29.0% PAT 1,187 1,355 -12.3% 1,069 11.1% 2,542 2,156 17.9% Net Margin (%) 19.9% 23.4% 21.0% 21.7% 21.6% 5 e Glenmark LIFE SCIENCES

View entire presentation